Eli Lilly (NYSE:LLY) opened Wednesday’s session with a blowout second-quarter earnings report, sending shares sharply higher and cementing the drugmaker’s status as the only pharmaceutical company trading above a $1 trillion market cap.
The biggest question today for Lilly is…
This post appeared first on 24/7 Wall St.